QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00807612. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a global, multicenter, 2-part, open-label phase 1b and single-arm phase 2 study designed to evaluate the safety and efficacy of AMG 479 in combination with paclitaxel and carboplatin for the first-line treatment of advanced squamous non-small cell lung carcinoma.
Study identification
- NCT ID
- NCT00807612
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2009 (Type not available)
- Primary completion
- Aug 2010 (Actual)
- Completion
- Aug 2010 (Actual)
- Last update posted
- Sep 25, 2024
2009 – 2010
United States locations
- U.S. sites
- 25
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Fayetteville | Arkansas | 72703 | — |
| Research Site | Fayetteville | Arkansas | — | — |
| Research Site | Fort Wayne | Indiana | 46845 | — |
| Research Site | Fort Wayne | Indiana | — | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Indianapolis | Indiana | 46256 | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Lafayette | Indiana | 47905 | — |
| Research Site | Lafayette | Indiana | — | — |
| Research Site | New Albany | Indiana | 47150 | — |
| Research Site | New Albany | Indiana | — | — |
| Research Site | Paducah | Kentucky | 42003 | — |
| Research Site | Paducah | Kentucky | — | — |
| Research Site | St Louis | Missouri | 63110-1093 | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Bethlehem | Pennsylvania | 18015 | — |
| Research Site | Bethlehem | Pennsylvania | — | — |
| Research Site | Greenville | South Carolina | 29605 | — |
| Research Site | Greenville | South Carolina | — | — |
| Research Site | Memphis | Tennessee | 38120 | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Madison | Wisconsin | 53792 | — |
| Research Site | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00807612, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2024 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00807612 live on ClinicalTrials.gov.